scispace - formally typeset
G

Garima Shukla

Researcher at All India Institute of Medical Sciences

Publications -  147
Citations -  1717

Garima Shukla is an academic researcher from All India Institute of Medical Sciences. The author has contributed to research in topics: Polysomnography & Epilepsy. The author has an hindex of 21, co-authored 133 publications receiving 1435 citations. Previous affiliations of Garima Shukla include Cleveland Clinic & Queen's University.

Papers
More filters
Journal ArticleDOI

What features differentiate unilateral from bilateral restless legs syndrome? A comparative observational study of 195 patients.

TL;DR: Unilateral RLS is not rare and although similar to bilateral RLS in clinical features, this entity may more often be secondary and less often associated with a positive family history, and would need further confirmation through future studies.
Journal ArticleDOI

Cognitive, behavioural and sleep-related adverse effects on introduction of levetiracetam versus oxcarbazepine for epilepsy

TL;DR: On cross-sectional as well as on longitudinal assessment, nearly one-fifth of patients on levetiracetam have behaviour related adverse effects, with dose modification required for half among these.
Journal ArticleDOI

Clinical spectrum of Hallervorden-Spatz syndrome in India.

TL;DR: The heterogeneity of Hallervorden-Spatz syndrome is highlighted and certain unusual clinical features are described, which were exclusively seen in late onset patients.
Journal ArticleDOI

Psychiatric co-morbidities and factors associated with psychogenic non-epileptic seizures: a case-control study

TL;DR: It is highlighted that several socio-economic and demographic factors are associated with occurrence of PNES, and high rates of psychiatric comorbidities including current suicide risk emphasise the need for a collaborative neuropsychiatric approach.
Journal ArticleDOI

Neuropsychiatric co-morbidities in non-demented Parkinson′s disease

TL;DR: Depression was more frequent in patients with higher disability and psychosis with longer duration of disease and older age, and these co-morbidities need to be addressed during management of patients with PD.